Bernstein Maintains Market Perform on Arrowhead Pharma, Raises Price Target to $46

Benzinga Newsdesk www.benzinga.com Positive 73.3%

Neg 0% Neu 0% Pos 73.3%

Bernstein analyst William Pickering maintains Arrowhead Pharma (NASDAQ:ARWR) with a Market Perform and raises the price target from $35 to $46.